





for	 the	 first	 time	 in	 the	 brain.	 It	was	 this	 ascertain-
ment	 that	 ten	years	 later	 led	scientists	 to	use	dietary	











lies	 of	 ionotropic	 receptors,	 named	 after	 their	 ago-































Glutamate’s	 receptors	 are	 classified	 in	 two	 large	
categories:
Glutamate receptors in blood elements  
and bone marrow megakaryocytes.
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N-methyl-D-asparate	 (NMDA),	 and	 those	character-
ized	by	 their	affinity	 to	 the	 synthetic	agonist	AMPA	
and	kainate	natural	neurotoxin10.
Glutamate	ionotropic	receptor	subunits	are	coded	
by	 at	 least	 6	 gene	 families	 (3	 for	NMDA	 receptors,	
one	for	AMPA	and	2	for	kainate).
The	sequence	homology	suggests	a	mutual	starting	
point	 of	 evolution	 as	 far	 as	 ionotropic	 receptors	 are	
concerned.
i. NMDA receptors
NMDA	 receptors	 are	mainly	 located	 at	 CNS’s	 syn-
apsis	 and	are	 composed	by	NR1	and	NR2	subunits.	






















Kainate	 is	 one	 of	 the	 most	 potent	 neurotoxin	





Like	AMPA	 receptors	 they	 can	mediate	 high	 ki-
netic	excitatory	stimuli,	and	they	are	also	involved	in	





a	 receptor	 ion	 channel.	Among	 those	 receptors	 and	











affinity	 concerning	 their	 agonists	 and	 co-agonists,	

















ron	 inhibits	 NMDA	 receptor	 blockage	 induced	 by	








mGluRs	 are	 part	 of	 a	 large	 family	 of	 proteins	with	
seven	 transmembrane	 sites	 and	 have	 been	 classified	
in	3	subgroups	based	on	their	homologous	sequence,	





Glutamate’s	 metabotropic	 receptors’	 activation	




















pancreas36-41	 esophagus42,	 hepatocytes43,44,	 heart45,46,	





found	 in	 peripheral	 blood	 elements	 and	 in	 the	 bone	
marow	cells.
All	 of	 the	 above	 suggest	 that	 glutamate	 act	 as	 a	
widespread	cytokine,	 that	can	affect	cell	 function	 in	
various	peripheral	tissues	outside	CNS.
Glutamate and t-cells
T-cells	 can	 encounter	 neurotransmitters	 in	 different	
parts	 of	 our	 body	 such	 as	 lymphoid	 organs,	 blood,	
peripheral	nervous	system	and	Central	Nervous	Sys-
tem.


























Recently,	G.	Miglio	et	 al	have	 suggested	 the	ex-
pression	of	sudunits’	NR1	and	NR2	genes	in	human	
cells.	 In	 fact	 the	presence	of	 the	NMDA	receptor	 in	







Moreover,	 glutamate	 was	 found	 to	 regulate	 the	
CXCR4-mediated	 T	 cell	 chemotactic	 migration	 to-
ward	 the	 key	 chemokine	 CXCL12/stromal	 cell-de-
rived	factor-1	encounted	both	in	CNS	and	in	periph-
eral	 tissues	 and	being	 of	 an	 important	 part	 in	many	
immune	and	neural	functions64.
Recently	 research	 showed	 that	 MK-801,	 a	 non-









There	 are	 not	 many	 papers	 published	 concerning	
glutamate,	 its	 receptors	 and	 their	 relationship	 with	
megakaryocytes,	nevertheless	the	results	existing,	are	
enough	 to	 show	another	gap	 in	our	knowledge	con-
cerning	glutamate’s	action	outside	CNS.
Research	proved	the	presence	of	NR1	and	NR2D	
subunits	 in	 human	 and	 rat	 megakaryocytes	 as	 well	
as	 in	MEG-01	cell	 line68.	 In	human	megakaryocytes	
there	 are	 also	NR2A	subunits	 as	well	 as	Yotaio	 and	
PSD-95	 helping	 protein69	 both	 important	 for	 intra-
cellular	 and	 cytoplasmic	 membrane	 changes,	 when	









The	 first	 clue	 that	 glutamate	 is	 affecting	 mega-







Glutamate and platelets 
In	1996,	Fanconi	et	al	proved	 that	glutamate	has	an	
anti-aggregating	 activity	 on	 platelets,	 primaly	 ex-
posed	to	arachidonic	acid	or	ADP	or	platelet	aggregat-
ing	factor	(PAF)72.
Platelet	 glutamate	 subunit	 receptors	 are	 in	 some	
ways	 different	 compared	 with	 CNS’	 receptors.	 For	
example,	when	it	comes	to	platelets,	the	presence	of	




Furthermore,	 NMDA’s	 anti-agreggating	 activity	
is	 affected	 in	 a	 negative	way	 by	 unusual	 high	 con-
centrations	of	non-competitive	antagonist	MK-80175,	
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